JEFFREY TATAR: Open Payments
NPI 1245401348 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 23 payments from 8 companies in 2025. Trend: 2023 $264 · 2024 $2,361 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $191 |
| Lilly USA, LLC | 3 | $170 |
| Galderma Laboratories, L.P. | 5 | $169 |
| Amgen Inc. | 1 | $121 |
| Organon LLC | 1 | $92 |
| Janssen Biotech, Inc. | 4 | $87 |
| ABBVIE INC. | 4 | $81 |
| GENZYME CORPORATION | 1 | $25 |
Products named: NEMLUVIO, TAVNEOS, VTAMA, TREMFYA, SKYRIZI, TALTZ, Bimzelx, DUPIXENT.
Industry payments across NY — which companies pay providers there.
